Kazumasa Matsumoto

Summary

Country: Japan

Publications

  1. ncbi [8-month neoadjuvant hormonal therapy before radical prostatectomy for high-risk prostate cancer]
    Ken-ichi Tabata
    Department of Urology, Kitasato University, School of Medicine
    Nippon Hinyokika Gakkai Zasshi 97:712-8. 2006
  2. ncbi Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer
    Kazumasa Matsumoto
    Department of Urology, School of Medicine Kitasato University, Tokyo, Japan
    Urology 72:444-9. 2008
  3. ncbi Thoracoscopic transdiaphragmatic adrenalectomy for isolated locally recurrent adrenal carcinoma
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan
    Int J Urol 12:1055-7. 2005
  4. ncbi Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, Kanagawa, Japan
    Int J Urol 14:1000-4; discussion 1004. 2007
  5. ncbi Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Urology 70:602-7. 2007
  6. ncbi Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Int J Urol 13:1290-5. 2006
  7. ncbi Distribution of lymphatic vessel network in normal urinary bladder
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan
    Urology 72:706-10. 2008
  8. ncbi Prostatic cystadenoma presenting as a large multilocular mass
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan
    Int J Urol 9:410-2. 2002
  9. ncbi Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy
    Masaomi Ikeda
    Department of Urology, Kitasato University School of Medicine, 1 15 1 Kitasato, Minami Ku, Sagamihara, Kanagawa 252 0374, Japan
    Jpn J Clin Oncol 41:1214-20. 2011
  10. ncbi Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial
    Hideyasu Tsumura
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Int J Radiat Oncol Biol Phys 81:e385-92. 2011

Collaborators

Detail Information

Publications57

  1. ncbi [8-month neoadjuvant hormonal therapy before radical prostatectomy for high-risk prostate cancer]
    Ken-ichi Tabata
    Department of Urology, Kitasato University, School of Medicine
    Nippon Hinyokika Gakkai Zasshi 97:712-8. 2006
    ..0545) and positive surgical margin (p = 0.0545). CONCLUSION: Biochemical failure was frequent after this combined treatment, even in a pT0 case. Long-term follow-up of patients is needed to assess the impact of this therapy on mortality...
  2. ncbi Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer
    Kazumasa Matsumoto
    Department of Urology, School of Medicine Kitasato University, Tokyo, Japan
    Urology 72:444-9. 2008
    ..This study aimed to detect UP III expression in transitional cell carcinoma (TCC) of the bladder and to determine whether the role of UP III heterogeneity is associated with predicting disease recurrence and patient survival...
  3. ncbi Thoracoscopic transdiaphragmatic adrenalectomy for isolated locally recurrent adrenal carcinoma
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan
    Int J Urol 12:1055-7. 2005
    ..There have been no signs of tumor recurrence during 3 years follow up after surgery. This approach provides a minimally invasive alternative to an open thoracoabdominal procedure after prior open surgery...
  4. ncbi Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, Kanagawa, Japan
    Int J Urol 14:1000-4; discussion 1004. 2007
    ..The objective of this study was to assess the tumor responses, toxicity, and overall survival of these patients as second-line treatment...
  5. ncbi Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Urology 70:602-7. 2007
    ..To determine the expression patterns and prognostic value of S100A2 and S100A4 in surgical specimens from radical cystectomy for transitional cell carcinoma of the urinary bladder...
  6. ncbi Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Int J Urol 13:1290-5. 2006
    ..The objective of this study was to use computer simulation to investigate the optimal biopsy scheme for enhancing the detection of cancer in palpably benign prostate glands...
  7. ncbi Distribution of lymphatic vessel network in normal urinary bladder
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan
    Urology 72:706-10. 2008
    ..The objective of this study was to determine the LYVE-1 expression patterns in normal urothelium and to compose the geometric topography of the lymphatic network...
  8. ncbi Prostatic cystadenoma presenting as a large multilocular mass
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan
    Int J Urol 9:410-2. 2002
    ..Physicians should at least be aware of the possibility of this disease entity before making treatment decisions...
  9. ncbi Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy
    Masaomi Ikeda
    Department of Urology, Kitasato University School of Medicine, 1 15 1 Kitasato, Minami Ku, Sagamihara, Kanagawa 252 0374, Japan
    Jpn J Clin Oncol 41:1214-20. 2011
    ....
  10. ncbi Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial
    Hideyasu Tsumura
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Int J Radiat Oncol Biol Phys 81:e385-92. 2011
    ....
  11. ncbi Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience
    Takefumi Satoh
    Department of Urology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, 228 8555, Japan
    Jpn J Radiol 27:348-54. 2009
    ..We examined changes in medical income and expenditure after this revision of the medical fee system...
  12. ncbi Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy
    Satoru Minamida
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Urology 78:1235-9. 2011
    ..E. coli is the pathogen most commonly associated with infections after TRUS-guided prostate biopsy, and the prevalence of fluoroquinolone-resistant E. coli is increasing...
  13. ncbi A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Japan
    BJU Int 108:831-8. 2011
    ....
  14. ncbi The radiotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin treatment is an effective therapeutic option in patients with advanced or metastatic bladder cancer
    Masaomi Ikeda
    Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan
    J Radiat Res 52:674-9. 2011
    ..Given the safety and benefit profile found in this study, appropriate case selection is warranted in the future...
  15. ncbi C-reactive protein as a prognostic marker for advanced renal cell carcinoma treated with sunitinib
    Tetsuo Fujita
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Int J Urol 19:908-13. 2012
    ..To investigate the prognostic role of C-reactive protein in patients with advanced renal cell carcinoma treated with sunitinib...
  16. ncbi 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid
    Satoru Minamida
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Anal Bioanal Chem 401:245-52. 2011
    ..8813) indicate a high degree of accuracy for this screening method. 14-3-3 Protein beta/alpha may be a diagnostically useful biomarker for early diagnosis of RCC...
  17. ncbi [Superficial bladder cancer with lung metastasis without local invasion: a case report]
    Takahiro Hirayama
    Department of Urology, Kitasato University School of Medicine
    Hinyokika Kiyo 53:179-82. 2007
    ..There have been no signs of recurrence during the six-year follow up. The case reported here is of superficial cancer with a metastatic lesion in the lung without local invasion in the urinary bladder...
  18. ncbi [Case report: a patient with bladder sarcoma exclusively treated with transurethral resection with long-term follow-up]
    Takahiro Hirayama
    Department of Urology, Kitasato University School of Medicine
    Nihon Hinyokika Gakkai Zasshi 100:576-9. 2009
    ..Immunohistochemical staining using conventional antibodies was not classified as the origin of this sarcoma. There have been no signs of recurrence during twenty years' follow-up after the treatment...
  19. ncbi Single infusion of zoledronic acid to prevent androgen deprivation therapy-induced bone loss in men with hormone-naive prostate carcinoma
    Takefumi Satoh
    Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan
    Cancer 115:3468-74. 2009
    ..The authors investigated the effectiveness of a single infusion of zoledronic acid initiated subsequent to ADT on BMD with hormone-naive prostate carcinoma...
  20. ncbi EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy
    Shinji Kurosaka
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Ann Nucl Med 26:485-91. 2012
    ..Sr-89 is an established alternative for the palliation of bone pain in prostate cancer. We aimed to assess the effect of Sr-89 radionuclide therapy on quality of life (QOL) in prostate cancer patients with painful bone metastases...
  21. ncbi Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis
    Takefumi Satoh
    Department of Urology, Kitasato University School of Medicine, Kangawa, Japan
    BJU Int 103:1064-8. 2009
    ....
  22. ncbi Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Int J Urol 12:353-60. 2005
    ..Further efforts to optimize biopsy schemes are warranted...
  23. ncbi Cytological significance of abnormal squamous cells in urinary cytology
    Manabu Hattori
    Department of Clinical Cytology, School of Allied Health Sciences, Kitasato University, Sagamihara, Kanagawa, Japan
    Diagn Cytopathol 40:798-803. 2012
    ..Necrotic debris was found not only in patients who had malignant bladder tumors but also in those who had malignant lesions in locations other than the bladder...
  24. ncbi Erythema multiforme induced by sorafenib for metastatic renal cell carcinoma
    Masaomi Ikeda
    Department of Urology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, Kanagawa 252 0374, Japan
    Jpn J Clin Oncol 42:820-4. 2012
    ..Although sorafenib-induced erythema multiforme is rarely reported, we evaluated the cases of erythema multiforme induced by sorafenib for metastatic renal cell carcinoma...
  25. ncbi Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy
    Hiromichi Ishiyama
    Department of Radiology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    Int J Radiat Oncol Biol Phys 75:23-8. 2009
    ....
  26. ncbi Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus Calmette-Guérin for superficial bladder cancer recurrence
    Akira Irie
    Department of Urology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, Kanagawa 228 8555, Japan
    Int J Urol 10:183-9. 2003
    ..Adverse effects of BCG are major obstacles, but the reduction of BCG dose could minimize these effects. The efficacy and adverse effects of half-dose (40 mg) BCG, Tokyo 172 strain, were prospectively evaluated...
  27. ncbi Nomogram to predict seminal vesicle invasion using the status of cancer at the base of the prostate on systematic biopsy
    Makoto Ohori
    Department of Urology, Tokyo Medical University, Tokyo, Japan
    Int J Urol 17:534-40. 2010
    ..The aim of this study was to predict seminal vesicle invasion (SVI) by developing a new nomogram based on clinical features including the status of cancer at the base of the prostate on systematic biopsy...
  28. ncbi Occupational bladder cancer: from cohort study to biologic molecular marker
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, Kanagawa, Japan
    Med Sci Monit 11:RA311-5. 2005
    ..Because of recent advances in molecular techniques, biologic markers have a potential role in screening for and monitoring of occupational bladder cancers...
  29. ncbi Efficacy and late complications of laparoscopic pyeloplasty: Experience involving 125 consecutive ureters
    Masatsugu Iwamura
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan
    Asian J Endosc Surg 6:116-21. 2013
    ..However, there have been insufficient reports describing the long-term outcomes and the stability of the results. In addition, late complications have not been thoroughly discussed...
  30. ncbi Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy
    Takefumi Satoh
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Urology 66:114-8. 2005
    ..To perform systemic 22-core transperineal ultrasound-guided template prostate biopsies in patients with previous negative transrectal ultrasound-guided prostate biopsy findings and evaluate the cancer core distribution...
  31. ncbi Ammonium acid urate urolithiasis in Japan
    Hidetoshi Kuruma
    Department of Urology, Jikei University School of Medicine, Tokyo, and Department of Urology, Sagamidai Hospital, Kanagawa, Japan
    Int J Urol 13:498-501. 2006
    ..Ammonium acid urate (AAU) calculi are a rare urolithiasis in developed countries but are endemic in developing countries. We assessed the features of AAU urolithiasis in Japanese patients...
  32. ncbi High molecular mass proteome of androgen-independent prostate cancer
    Hidetoshi Kuruma
    Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan
    Proteomics 5:1097-112. 2005
    ..The proteomic approach, using agarose 2-DE focused on HMM proteins, has the capability to find novel biomarkers of prostate cancer...
  33. ncbi [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma]
    Kazumasa Matsumoto
    Department of Urology, Kitasato University School of Medicine
    Nippon Hinyokika Gakkai Zasshi 93:548-54. 2002
    ..In particular, patients with clinically curable tumors (pT1-3N0M0), whose preoperative IAP levels greater then 620 ug/ml may have high risk for recurrence after radical nephrectomy...
  34. ncbi Prospective evaluation of prostate cancer detection by prostate specific antigen related parameters: comparison in serum and plasma samples
    Shin Egawa
    Departments of Urology and Pathology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    J Urol 167:97-102. 2002
    ..Continued use of serum samples is justified for measuring PSA related parameters by current assay techniques...
  35. ncbi Laparoscopic radical cystectomy and bilateral ureteric ligation for muscle-invasive bladder cancer in a patient on hemodialysis
    Daisuke Ishii
    Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan
    Int J Urol 13:1009-11. 2006
    ..No complications were seen perioperatively and no adverse events regarding ureteric ligation arose. HD was performed on the second postoperative day. At a 12-month follow-up, the patient showed no evidence of disease...
  36. ncbi Angiolymphoid hyperplasia with eosinophilia on penile skin in a 7-year-old child
    Morihiro Nishi
    Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan
    J Pediatr Surg 46:559-61. 2011
    ..In this situation, treatment of this tumor should be considered carefully, and there is a chance of spontaneous regression after volume reduction surgery...
  37. ncbi Immunohistochemical, molecular, and clinicopathological analyses of urothelial carcinoma, micropapillary variant
    Shuhei Ishii
    Department of Biological Structure, Cellular and Histopathology, Kitasato University Graduate School of Medical, Kanagawa, Japan
    Pathol Int 61:723-30. 2011
    ..Occupation rate of the MPV area in the tumor showed significant inverse correlation with overall survival. Thus our histopathological findings provide clues to explaining why prognosis is poorer in the MPV than UC...
  38. ncbi Transurethral ureterolithotripsy and extracorporeal shock wave lithotripsy in patients with idiopathic thrombocytopenic purpura
    Toshiki Tsuboi
    Department of Urology, Kitasato University School of Medicine
    Hinyokika Kiyo 54:17-22. 2008
    ..This is the first case report of ITP being treated by ESWL after high-dose gamma-globulin therapy. High-dose gamma-globulin therapy effectively provides adequate platelet counts for surgical treatment in patients with ITP...
  39. ncbi [A case of genital Chlamydia trachomatis infection with acute post renal failure]
    Takahiro Hirayama
    Department of Urology, Kitasato University School of Medicine
    Hinyokika Kiyo 54:301-4. 2008
    ..There have been no signs of hydronephroses or renal failure during six years' follow-up after the treatment. We discus this rare case of bilateral hydronephroses due to genital Chlamydia trachomatis...
  40. ncbi [Clinical characteristics in patients with purple urine bag syndrome]
    Hideyasu Tsumura
    Department of Urology, Kitasato University School of Medicine
    Hinyokika Kiyo 54:185-8. 2008
    ..2+/-3.08 vs. 12.4+/-3.20, respectively, p=0.0275). These data suggest that strong alkaline urine acts as an important factor in PUBS, in combination with other facilitating factors...
  41. ncbi Immunohistochemical biomarkers for bladder cancer prognosis
    Kazuhito Matsushita
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Int J Urol 18:616-29. 2011
    ..There is no doubt that biomarkers will eventually guide our clinical decision making regarding follow-up scheduling and treatment choice...
  42. ncbi Tumor apoptosis in prostate cancer by PGD(2) and its metabolite 15d-PGJ(2) in murine model
    Masaki Nakamura
    Department of Environmental Microbiology, Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan
    Biomed Pharmacother 67:66-71. 2013
    ..Our results strongly suggested that the apoptosis induced in RM9-mPGDS in vivo was probably achieved in tumor environment such as hypoxic condition. The introduction of PGDS gene into cancer cells might be a novel therapy against cancer...
  43. ncbi Cell cannibalism and nucleus-fragmented cells in voided urine: useful parameters for cytologic diagnosis of low-grade urothelial carcinoma
    Manabu Hattori
    Department of Clinical Cytology, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan
    Acta Cytol 51:547-51. 2007
    ..To clarify whether the 3 parameters of cell clusters, cell cannibalism and nucleus-fragmented cells could improve diagnostic accuracy for grade 1 urothelial carcinoma (G1UC)...
  44. ncbi Proteomic study of sera from patients with bladder cancer: usefulness of S100A8 and S100A9 proteins
    Sho Minami
    Department of Molecular Diagnosis, Kitasato University Graduate School of Medical Sciences, Sagamihara, Kanagawa 228 8555, Japan
    Cancer Genomics Proteomics 7:181-9. 2010
    ..05). These findings may help to identify biologically aggressive tumors and, thus, patients who might benefit from more intensive adjuvant therapy...
  45. ncbi Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study
    Kazumasa Matsumoto
    Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    BJU Int 108:E304-9. 2011
    ....
  46. ncbi Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical School 5323 Harry Hines Blvd, Dallas, Texas 75390 9110, USA
    Eur Urol 48:69-76. 2005
    ..To test the hypothesis that elevated urinary levels of soluble E-cadherin (sE-cadherin) would aid in the detection of transitional cell carcinoma (TCC) of the urinary bladder...
  47. ncbi The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer
    Michael W Kattan
    Scott Department of Urology, Baylor College of Medicine, 6535 Fannin St, Houston, TX 77030, USA
    J Clin Oncol 21:3573-9. 2003
    ....
  48. ncbi Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder
    Shanrokh F Shariat
    Scott Department of Urology, Baylor College of Medicine, 6560 Fannin, Houston, TX 77030, USA
    J Urol 170:985-9. 2003
    ..While COX-2 expression has limited prognostic value in patients with bladder TCC, it may serve as a target for therapy with selective COX-2 inhibitors...
  49. ncbi Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy
    Kazumasa Matsumoto
    Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Urol 170:2248-52. 2003
    ..These patients may benefit from more extensive lymph node dissection and/or combined modality treatment regimens...
  50. ncbi [Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy]
    Masaki Kimura
    Department of Urology, Kitasato University of Medicine
    Nihon Hinyokika Gakkai Zasshi 99:22-8. 2008
    ..Androgen deprivation therapy (ADT) in patients with prostate cancer is associated with bone loss. We investigated the effectiveness of risedronate about a decreasing bone mineral density in patients with prostate cancer on ADT...
  51. ncbi [Sudden death after 125I brachytherapy in prostate cancer patient: a case report]
    Masaki Kimura
    Departments of Urology, Kitasato University School of Medicine
    Nippon Hinyokika Gakkai Zasshi 96:560-3. 2005
    ..Treatment of prostate cancer with brachytherapy has increased in Japan, and we should establish management manual for sudden death case after 125I brachytherapy...
  52. ncbi [A case report: small cell carcinoma transformed from transitional cell carcinoma of the urinary bladder]
    Takahiro Hirayama
    The Department of Urology, Kitasato University School of Medicine
    Hinyokika Kiyo 52:633-5. 2006
    ..Immunohistochemical staining using chromogranin A and synaptophysin was positive in the latest TURBT and the radical cystectomy specimens. We report a case of primary small cell carcinoma transformed from TCC of the urinary bladder...
  53. ncbi [Cranial nerve palsies due to skull base metastases in patients with prostate cancer: a report of two cases]
    Masaki Kimura
    Departments of Urology, Kitasato University School of Medicine
    Nippon Hinyokika Gakkai Zasshi 97:748-51. 2006
    ..Magnetic resonance imaging showed low intensity in the clivus in both cases, and all over the skull in case 2. The first patient was treated with radiation therapy and intravenous steroids at an early date. His symptoms improved...
  54. ncbi [A case report: Bilharzial schistosomiasis in the urinary bladder presented with gross hematuria]
    Toshiki Tsuboi
    The Department of Urology, Kitasato University School of Medicine
    Hinyokika Kiyo 52:281-3. 2006
    ..There have been no signs of recurrence during the one-year follow up except for excretion of degenerated eggs of schistosome haematobium in the urine specimens...
  55. ncbi Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer
    Kazumasa Matsumoto
    Scott Department of Urology, Baylor College of Medicine, Methodist Hospital, Houston, Texas, USA
    Urology 66:441-6. 2005
    ..The association of CAR with E-cadherin and p53 suggests a potential role for CAR in the regulation of urothelium integrity and the cell cycle...
  56. ncbi [Incidental inverted papilloma during the clinical follow-up of superficial transitional cell carcinoma in the urinary bladder]
    Haruko Sasamoto
    The Department of Urology, Kitasato University School of Medicine
    Hinyokika Kiyo 54:131-4. 2008
    ..The case reported here had a very rare pathologic finding with a history of superficial tumors located in the same areas in the urinary bladder...